Order Article Reprints

Farhoumand LS, Fiorentzis M, Kraemer MM, Sak A, Stuschke M, Rassaf T, Hendgen-Cotta U, Bechrakis NE, Berchner-Pfannschmidt U. The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers. 2022; 14(13):3097. https://doi.org/10.3390/cancers14133097

Farhoumand, Lina S., Miltiadis Fiorentzis, Miriam M. Kraemer, Ali Sak, Martin Stuschke, Tienush Rassaf, Ulrike Hendgen-Cotta, Nikolaos E. Bechrakis, and Utta Berchner-Pfannschmidt. 2022. "The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation" Cancers 14, no. 13: 3097. https://doi.org/10.3390/cancers14133097

Farhoumand, L. S., Fiorentzis, M., Kraemer, M. M., Sak, A., Stuschke, M., Rassaf, T., Hendgen-Cotta, U., Bechrakis, N. E., & Berchner-Pfannschmidt, U. (2022). The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers, 14(13), 3097. https://doi.org/10.3390/cancers14133097